09 October 2018

Breast Cancer Awareness Month

  • Càncer

New therapeutic strategies for breast cancer

The risk of developing breast cancer is largely determined by the ability of the cells to repair damage to their DNA and, at the same time, by the regulation of the "stem cells" that may eventually become tumors. However, it is unknown how these two fundamental processes co-regulate.


05 October 2018
  • Càncer

Statement on Dr Manel Esteller leaving IDIBELL

The Bellvitge Biomedical Research Institute (IDIBELL) states that Dr Manel Esteller, ICREA researcher, professor at the University of Barcelona, and until now, coordinator of the Epigenetics and Cancer Biology Program (PEBC) at IDIBELL, has been appointed director of the Josep Carreras Leukaemia

03 October 2018

Dr. Álvaro Aytés.
This Project is supported by the Assistance Secretary of Defense for Health Affairs, through the Prostate Cancer Research Program, endorsed by The Department of Defense under Award No. W81XWH1810193

  • Càncer

400,000 dollars to fight prostate cancer

Researcher Álvaro Aytés, head of the Cancer Prostate group at IDIBELL-ICO (Program Against Cancer Resistance, ProCURE, Oncobell), has received an Idea Development Award, worth 400,000 $, from the Congressionally Directed Medical Research Program (CDMRP) of the American Department of Defense (DoD)

02 October 2018
  • Càncer

Bioinformatics deciphers the metabolic characteristics of 25 types of cancer

Through a bioinformatics analysis of a large amount of data, researchers from IDIBELL ¡-ICO (ProCURE, Oncobell program) have helped unveil the metabolic characteristics of several types of cancer.

29 September 2018
  • Neurociències

The 1st European Day GRIN2B brings together families suffering from this rare illness in Barcelona

Approximately 25 families from all over Europe will attend the conference halls of Hospital Sant Joan de Déu in Barcelona on September 29th.